Medipure Pharmaceuticals Inc. ("MPI") and Medipure Holdings Inc. ("MHI") both filed a Notice of Intention to Make a Proposal ("NOI") on May 11, 2022 pursuant to Section 50.4(1) of the Bankruptcy and Insolvency Act (the "BIA"). Pursuant to Section 69 of the BIA, all proceedings against MPI and MHI are stayed as of that date. Publicly available documents related to these proceedings will be posted to this website.
If you have any questions on this matter, please contact Jordan Yin of the
Trustee's office at 604-640-5089 or firstname.lastname@example.org
Jun 27, 2022